Critchlow, Susan E.
AstraZeneca (United Kingdom)
4 papers on CoChatORCID 0000-0002-4647-8988
Most cited papers
- Verified
Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress
Schug, Z. T., Peck, B., Jones, D. T., Zhang, Q., Grosskurth, S., Alam, I. S., Goodwin, L. M., Smethurst, E., Mason, S., Blyth, K., et al. (2015) · Cancer Cell
Cancer, Lipids, and MetabolismCancer, Hypoxia, and Metabolism
Cited by 820
- Verified
AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity
Chresta, C. M., Davies, B. R., Hickson, I., Harding, T., Cosulich, S., Critchlow, S. E., Vincent, J. P., Ellston, R., Jones, D., Sini, P., et al. (2010) · Cancer Research
PI3K/AKT/mTOR signaling in cancerAutophagy in Disease and Therapy
Cited by 812
- Verified
DNA end-joining: from yeast to man
Critchlow, S. E., & Jackson, S. P. (1998) · Trends in Biochemical Sciences
DNA Repair MechanismsNuclear Structure and Function
Cited by 584
- Verified
Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer
Polański, R., Hodgkinson, C. L., Fusi, A., Nonaka, D., Priest, L., Kelly, P., Trapani, F., Bishop, P. W., White, A., Critchlow, S. E., et al. (2014) · Clinical Cancer Research
Cancer, Hypoxia, and MetabolismLung Cancer Research Studies
Cited by 378
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free